Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 12, 2017
Clinical News

TGR-1202: Ph IIa started

BioCentury | Dec 2, 2016
Clinical News

TG-1202: Ph III ongoing

BioCentury | Oct 31, 2016
Clinical News

TGR-1202: Phase I/II started

BioCentury | Jun 13, 2016
Clinical News

TGR-1202: Phase IIb started

BioCentury | Jan 18, 2016
Clinical News

TGR-1202: Additional Phase I data

BioCentury | Sep 28, 2015
Clinical News

TGR-1202: Phase I/II started

BioCentury | Jan 26, 2015
Clinical News

TGR-1202: Additional Phase I/II data

BioCentury | Dec 15, 2014
Clinical News

TGR-1202: Phase I started

BioCentury | Aug 11, 2014
Clinical News

TGR-1202: Preliminary Phase I data

Items per page:
1 - 10 of 17